SOLID DOSAGE FORMS AND DOSING REGIMENS COMPRISING (2R,3S,4S,5R)-4-[[3-(3,4-DIFLUORO-2-METHOXY-PHENYL)-4,5-DIMETHYL-5-(TRIFLUOROMETHYL) TETRAHYDROFURAN-2-CARBONYL]AMINO]PYRIDINE-2-CARBOXAMIDE

Provided is a solid dispersion of (2R,3S,4S,5R)-4-[[3-(3,4-difluoro-2-methoxy-phenyl)-4,5-dimethyl-5-(trifluoromethyl) tetrahydrofuran-2-carbonyl]amino]pyridine-2-carboxamide (Compound 1), defined as described herein, or a pharmaceutically acceptable salt thereof and a tablet containing the solid di...

Full description

Saved in:
Bibliographic Details
Main Authors CORRELL, Darin J, CIRINCIONE, Brenda, STAROPOLI, John F, KARKARE, Radhika, BENITO GALLO, Paloma, HAY, Tanya Louise, MCCARTY, Katie L, DELFF, Philip Kaj Harder, METZLER, Catherine P, JONES, James B, MILLER, Jonathan M, DINEHART, Kirk Raymond, ROOPWANI, Rahul, PETERSON, Mark C, CHU, Cathy, JIANG, Licong
Format Patent
LanguageEnglish
French
German
Published 10.04.2024
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Provided is a solid dispersion of (2R,3S,4S,5R)-4-[[3-(3,4-difluoro-2-methoxy-phenyl)-4,5-dimethyl-5-(trifluoromethyl) tetrahydrofuran-2-carbonyl]amino]pyridine-2-carboxamide (Compound 1), defined as described herein, or a pharmaceutically acceptable salt thereof and a tablet containing the solid dispersion for treating pain. Also disclosed herein is Compound 1 or a pharmaceutically acceptable salt thereof for use in a method of treating pain.
AbstractList Provided is a solid dispersion of (2R,3S,4S,5R)-4-[[3-(3,4-difluoro-2-methoxy-phenyl)-4,5-dimethyl-5-(trifluoromethyl) tetrahydrofuran-2-carbonyl]amino]pyridine-2-carboxamide (Compound 1), defined as described herein, or a pharmaceutically acceptable salt thereof and a tablet containing the solid dispersion for treating pain. Also disclosed herein is Compound 1 or a pharmaceutically acceptable salt thereof for use in a method of treating pain.
Author ROOPWANI, Rahul
MCCARTY, Katie L
DELFF, Philip Kaj Harder
CHU, Cathy
JIANG, Licong
PETERSON, Mark C
METZLER, Catherine P
STAROPOLI, John F
DINEHART, Kirk Raymond
JONES, James B
KARKARE, Radhika
BENITO GALLO, Paloma
HAY, Tanya Louise
CIRINCIONE, Brenda
MILLER, Jonathan M
CORRELL, Darin J
Author_xml – fullname: CORRELL, Darin J
– fullname: CIRINCIONE, Brenda
– fullname: STAROPOLI, John F
– fullname: KARKARE, Radhika
– fullname: BENITO GALLO, Paloma
– fullname: HAY, Tanya Louise
– fullname: MCCARTY, Katie L
– fullname: DELFF, Philip Kaj Harder
– fullname: METZLER, Catherine P
– fullname: JONES, James B
– fullname: MILLER, Jonathan M
– fullname: DINEHART, Kirk Raymond
– fullname: ROOPWANI, Rahul
– fullname: PETERSON, Mark C
– fullname: CHU, Cathy
– fullname: JIANG, Licong
BookMark eNqNjL1qwzAUhT20Q3_yDhodkIZEcsmqWNe2wNY1VwpEhBBCUKfiBNLn67NVTdO904HvfOc8Fw_TeUpPxZfH3hpm0OsWWIM0eKbdDVjXMoLWDuA8q3EYyd5YuSQuPVeeVzQXSux2UpSSK2Fs02-QUCzFAKHDbRRjBy722eJVrn9o7EUlykB39xfNWYBAuouGsNmQdvmi1rTGPN7rwTrcj5GssQ7-mm3GBl6Lx_fjxzXN7vlSsAZC3Yl0OR_S9XI8pSl9HmBUUr2tFiu9kP9QvgGIrU3a
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
DocumentTitleAlternate FORMES GALÉNIQUES SOLIDES ET SCHÉMAS POSOLOGIQUES COMPRENANT DU (2R,3S,4S,5R)-4-[[3-(3,4-DIFLUORO-2-MÉTHOXY-PHÉNYL)-4,5-DIMÉTHYL-5-(TRIFLUOROMÉTHYL)TÉTRAHYDROFURAN-2-CARBONYL]AMINO]PYRIDINE-2-CARBOXAMIDE
FESTE DOSIERFORMEN UND DOSIERSCHEMATA MIT (2R,3S,4S,5R)-4-[3-(3,4-DIFLUOR-2-METHOXY-PHENYL)-4,5-DIMETHYL-5-(TRIFLUORMETHYL)TETRAHYDROFURAN-2-CARBONYL)AMINO)PYRIDIN-2-CARBOXAMID
ExternalDocumentID EP4346818A1
GroupedDBID EVB
ID FETCH-epo_espacenet_EP4346818A13
IEDL.DBID EVB
IngestDate Fri Sep 06 06:22:15 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
French
German
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_EP4346818A13
Notes Application Number: EP20220741050
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240410&DB=EPODOC&CC=EP&NR=4346818A1
ParticipantIDs epo_espacenet_EP4346818A1
PublicationCentury 2000
PublicationDate 20240410
PublicationDateYYYYMMDD 2024-04-10
PublicationDate_xml – month: 04
  year: 2024
  text: 20240410
  day: 10
PublicationDecade 2020
PublicationYear 2024
RelatedCompanies Vertex Pharmaceuticals Incorporated
RelatedCompanies_xml – name: Vertex Pharmaceuticals Incorporated
Score 3.5303102
Snippet Provided is a solid dispersion of (2R,3S,4S,5R)-4-[[3-(3,4-difluoro-2-methoxy-phenyl)-4,5-dimethyl-5-(trifluoromethyl)...
SourceID epo
SourceType Open Access Repository
SubjectTerms HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title SOLID DOSAGE FORMS AND DOSING REGIMENS COMPRISING (2R,3S,4S,5R)-4-[[3-(3,4-DIFLUORO-2-METHOXY-PHENYL)-4,5-DIMETHYL-5-(TRIFLUOROMETHYL) TETRAHYDROFURAN-2-CARBONYL]AMINO]PYRIDINE-2-CARBOXAMIDE
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240410&DB=EPODOC&locale=&CC=EP&NR=4346818A1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3fS8MwEA5jivqmU_E3fZCxQYPrms7tYUjXpGtlTUraycoY4pYKvkzRiv-df5vX2k1f9C18l97Dhct318slCF2SThviip6BgcwVJmShcP6cFVZmmqZz2B0JybuRA97xxuR2Yk0q6GnVC1PcE_pRXI4IHrUAf8-K_frl5ycWLc5Wvl3NnwB6vnHjPq2X2THQEzFadTros1BQ4dQdB0Z1LvvEJB3gJhsSpQ2Ioq9zZ2B3g7wp5eU3o7i7aDMEZctsD1XSZQ1tO6uH12poKyjr3TAsXe9tH31GYuRTjYq8BqRB7hZEms0LwOdDTbKhHzAeaY4IQukXWKMtdTPSSaRbsokJnk5N3DB1gqnvjsZCCtzGAYs9MUlw6DGejGCWboE4R5MRtnAjluXcb6ipxSyWtpdQKdyxtDmocGw5EPDxzA58LmZhIn3qc7aSTACm7ABpLosdD4Mh7tdGv2fh2mTmIaoun5fpEdIeut2H65ay1MIwSddU3UWPKAUxTbv3qDpGeoyO_1Rz8o_sFO3kq5eXaYzWGapmr-_pObB9Nr8o1ukLEwmf_A
link.rule.ids 230,309,783,888,25576,76876
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwEA-ior75id_2QcaEBtc1ndvDkK5JbbRNStrJypDhlgq-zOEm_nf-bV7rpr7oW_hdeg8XLr-7Xi5B6Jw06hBXtCwMZK4xISONi-essLbzPB_C7khI0Y0ciUbQJbc9p7eEnhe9MOU9oe_l5YjgUSPw91m5X09-fmLR8mzl9HL4DNDLtZ-2aWWeHQM9EatWoZ02iyWVXsXzYFQRqk1s0gBuciFRWoEI-6pwBnbfKZpSJr8Zxd9EqzEoG8-20FI-3kbr3uLhtW20Fs3r3TCcu950B30kMuTUoLKoARmQu0WJ4YoS4OLGUOyGR0wkhiejWPESq9aVaScmSUxHXWCC-30bV22TYMr9sCuVxHUcsTSQvQzHARNZCLNMB8QFmoXYwdVUzed-QRdGylLlBhlV0u8qV4AKz1UdCR8_uBEX8iHOFKdcsIWkBzBlu8jwWeoFGAwx-Db6gMXfJrP30PL4ZZzvI-Ox2Xy8qmlHjyybNG3dHLWI1hDT1FtPumHlB-jgTzWH_8jO0HqQRuEg5OLuCG0UK1mUbKzaMVqevb7lJ8D8s-FpuWafw9yi7w
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=SOLID+DOSAGE+FORMS+AND+DOSING+REGIMENS+COMPRISING+%282R%2C3S%2C4S%2C5R%29-4-%5B%5B3-%283%2C4-DIFLUORO-2-METHOXY-PHENYL%29-4%2C5-DIMETHYL-5-%28TRIFLUOROMETHYL%29+TETRAHYDROFURAN-2-CARBONYL%5DAMINO%5DPYRIDINE-2-CARBOXAMIDE&rft.inventor=CORRELL%2C+Darin+J&rft.inventor=CIRINCIONE%2C+Brenda&rft.inventor=STAROPOLI%2C+John+F&rft.inventor=KARKARE%2C+Radhika&rft.inventor=BENITO+GALLO%2C+Paloma&rft.inventor=HAY%2C+Tanya+Louise&rft.inventor=MCCARTY%2C+Katie+L&rft.inventor=DELFF%2C+Philip+Kaj+Harder&rft.inventor=METZLER%2C+Catherine+P&rft.inventor=JONES%2C+James+B&rft.inventor=MILLER%2C+Jonathan+M&rft.inventor=DINEHART%2C+Kirk+Raymond&rft.inventor=ROOPWANI%2C+Rahul&rft.inventor=PETERSON%2C+Mark+C&rft.inventor=CHU%2C+Cathy&rft.inventor=JIANG%2C+Licong&rft.date=2024-04-10&rft.externalDBID=A1&rft.externalDocID=EP4346818A1